{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T07:59:10Z","timestamp":1791273550014,"version":"4.1.0"},"reference-count":66,"publisher":"American Society for Microbiology","issue":"8","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2014,8]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            <jats:named-content xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" content-type=\"genus-species\" xlink:type=\"simple\">Candida glabrata<\/jats:named-content>\n            , the second most common cause of\n            <jats:named-content xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" content-type=\"genus-species\" xlink:type=\"simple\">Candida<\/jats:named-content>\n            infections, is associated with high rates of mortality and often exhibits resistance to the azole class of antifungal agents. Upc2 and Ecm22 in\n            <jats:named-content xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" content-type=\"genus-species\" xlink:type=\"simple\">Saccharomyces cerevisiae<\/jats:named-content>\n            and Upc2 in\n            <jats:named-content xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" content-type=\"genus-species\" xlink:type=\"simple\">Candida albicans<\/jats:named-content>\n            are the transcriptional regulators of\n            <jats:italic>ERG11<\/jats:italic>\n            , the gene encoding the target of azoles in the ergosterol biosynthesis pathway. Recently two homologs for these transcription factors,\n            <jats:italic>UPC2A<\/jats:italic>\n            and\n            <jats:italic>UPC2B<\/jats:italic>\n            , were identified in\n            <jats:named-content xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" content-type=\"genus-species\" xlink:type=\"simple\">C. glabrata<\/jats:named-content>\n            . One of these,\n            <jats:italic>UPC2A<\/jats:italic>\n            , was shown to influence azole susceptibility. We hypothesized that due to the global role for Upc2 in sterol biosynthesis in\n            <jats:named-content xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" content-type=\"genus-species\" xlink:type=\"simple\">S. cerevisiae<\/jats:named-content>\n            and\n            <jats:named-content xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" content-type=\"genus-species\" xlink:type=\"simple\">C. albicans<\/jats:named-content>\n            , disruption of\n            <jats:italic>UPC2A<\/jats:italic>\n            would enhance the activity of fluconazole in both azole-susceptible dose-dependent (SDD) and -resistant\n            <jats:named-content xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" content-type=\"genus-species\" xlink:type=\"simple\">C. glabrata<\/jats:named-content>\n            clinical isolates. To test this hypothesis, we constructed mutants with disruptions in\n            <jats:italic>UPC2A<\/jats:italic>\n            and\n            <jats:italic>UPC2B<\/jats:italic>\n            alone and in combination in a matched pair of clinical azole-SDD and -resistant isolates. Disruption of\n            <jats:italic>UPC2A<\/jats:italic>\n            in both the SDD and resistant isolates resulted in increased susceptibility to sterol biosynthesis inhibitors, including a reduction in fluconazole MIC and minimum fungicidal concentration, enhanced azole activity by time-kill analysis, a decrease in ergosterol content, and downregulation of baseline and inducible expression of several sterol biosynthesis genes. Our results indicate that Upc2A is a key regulator of ergosterol biosynthesis and is essential for resistance to sterol biosynthesis inhibitors in\n            <jats:named-content xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" content-type=\"genus-species\" xlink:type=\"simple\">C. glabrata<\/jats:named-content>\n            . Therefore, the\n            <jats:italic>UPC2A<\/jats:italic>\n            pathway may represent a potential cotherapeutic target for enhancing azole activity against this organism.\n          <\/jats:p>","DOI":"10.1128\/aac.02217-13","type":"journal-article","created":{"date-parts":[[2014,5,28]],"date-time":"2014-05-28T07:08:08Z","timestamp":1401260888000},"page":"4543-4554","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":60,"title":["<i>UPC2A<\/i>\n            Is Required for High-Level Azole Antifungal Resistance in Candida glabrata"],"prefix":"10.1128","volume":"58","author":[{"given":"Sarah G.","family":"Whaley","sequence":"first","affiliation":[{"name":"Department of Clinical Pharmacy, College of Pharmacy, University of Tennessee Health Science Center, Memphis, Tennessee, USA"},{"name":"Children's Foundation Research Center at Le Bonheur Children's Medical Center, Memphis, Tennessee, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly E.","family":"Caudle","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, College of Pharmacy, University of Tennessee Health Science Center, Memphis, Tennessee, USA"},{"name":"Children's Foundation Research Center at Le Bonheur Children's Medical Center, Memphis, Tennessee, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John-Paul","family":"Vermitsky","sequence":"additional","affiliation":[{"name":"Femeris Women's Health Research Center, Medical Diagnostic Laboratories, L.L.C., Genesis Biotechnology Group, Hamilton, New Jersey, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean G.","family":"Chadwick","sequence":"additional","affiliation":[{"name":"Femeris Women's Health Research Center, Medical Diagnostic Laboratories, L.L.C., Genesis Biotechnology Group, Hamilton, New Jersey, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey","family":"Toner","sequence":"additional","affiliation":[{"name":"Femeris Women's Health Research Center, Medical Diagnostic Laboratories, L.L.C., Genesis Biotechnology Group, Hamilton, New Jersey, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine S.","family":"Barker","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, College of Pharmacy, University of Tennessee Health Science Center, Memphis, Tennessee, USA"},{"name":"Department of Pediatrics, College of Medicine, University of Tennessee Health Science Center, Memphis, Tennessee, USA"},{"name":"Children's Foundation Research Center at Le Bonheur Children's Medical Center, Memphis, Tennessee, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott E.","family":"Gygax","sequence":"additional","affiliation":[{"name":"Femeris Women's Health Research Center, Medical Diagnostic Laboratories, L.L.C., Genesis Biotechnology Group, Hamilton, New Jersey, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. David","family":"Rogers","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, College of Pharmacy, University of Tennessee Health Science Center, Memphis, Tennessee, USA"},{"name":"Department of Pediatrics, College of Medicine, University of Tennessee Health Science Center, Memphis, Tennessee, USA"},{"name":"Children's Foundation Research Center at Le Bonheur Children's Medical Center, Memphis, Tennessee, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_3_2_2","volume-title":"Candida and candidosis: a review and bibliography","author":"Odds FC","year":"1988","unstructured":"OddsFC. 1988. Candida and candidosis: a review and bibliography, 2nd ed. Bailliere Tindall, London, United Kingdom.","edition":"2"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.47.10.3149-3154.2003"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0732-8893(98)00160-6"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1080\/00365540410021126"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-006-0150-y"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2005.03.005"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.02485-07"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cis021"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.43.4.1829-1835.2005"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1086\/378745"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00462-08"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.44.2.529-535.2006"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.41.2.619-622.2003"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.48.10.3773-3781.2004"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.25.16.7375-7385.2005"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.48.4.1136-1144.2004"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1042\/BST20051215"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/29.10.2181"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1128\/EC.00073-10"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1128\/EC.00103-08"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01102-09"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1002\/pmic.200900176"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00995-10"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2443.2010.01470.x"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.11.2.382"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1128\/JB.183.3.830-834.2001"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.21.19.6395-6405.2001"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.49.5.1745-1752.2005"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1128\/EC.3.6.1391-1397.2004"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1128\/EC.00070-08"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.39.12.2708"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.06253-11"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2004.06.021"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1101\/pdb.prot4149"},{"key":"e_1_3_3_36_2","volume-title":"Approved standard M27-A3","author":"CLSI","year":"2008","unstructured":"CLSI. 2008. Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard M27-A3, 3rd ed. Clinical and Laboratory Standards Institute, Wayne, PA.","edition":"3"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000753"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.47.3.956-964.2003"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.36.10.2950-2956.1998"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.43.11.2753"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.42.5.1207"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.37.10.3332-3337.1999"},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/18.10.3091"},{"key":"e_1_3_3_44_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.49.6.2226-2236.2005"},{"key":"e_1_3_3_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2012.06.012"},{"key":"e_1_3_3_46_2","doi-asserted-by":"publisher","DOI":"10.1128\/EC.00130-10"},{"key":"e_1_3_3_47_2","doi-asserted-by":"publisher","DOI":"10.1128\/EC.00331-06"},{"key":"e_1_3_3_48_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.44.10.2693-2700.2000"},{"key":"e_1_3_3_49_2","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.16.10.5427"},{"key":"e_1_3_3_50_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00308-13"},{"key":"e_1_3_3_51_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(01)01130-5"},{"key":"e_1_3_3_52_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.12.4.501"},{"key":"e_1_3_3_53_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.36.7.1886-1889.1998"},{"key":"e_1_3_3_54_2","first-page":"1161","article-title":"Mucosal candidal colonization and candidiasis in women with or at risk for human immunodeficiency virus infection","volume":"27","author":"Schuman P","year":"1998","unstructured":"SchumanPSobelJDOhmitSEMayerKHCarpenterCCRompaloADuerrASmithDKWarrenDKleinRS. 1998. Mucosal candidal colonization and candidiasis in women with or at risk for human immunodeficiency virus infection. HIV Epidemiology Research Study (HERS) Group. Clin. Infect. Dis. 27:1161\u20131167.","journal-title":"HIV Epidemiology Research Study (HERS) Group. Clin. Infect. Dis."},{"key":"e_1_3_3_55_2","doi-asserted-by":"publisher","DOI":"10.1086\/342300"},{"key":"e_1_3_3_56_2","doi-asserted-by":"publisher","DOI":"10.1086\/514746"},{"key":"e_1_3_3_57_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.48.5.1773-1777.2004"},{"key":"e_1_3_3_58_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.43.5.2155-2162.2005"},{"key":"e_1_3_3_59_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000268"},{"key":"e_1_3_3_60_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.50.4.1384-1392.2006"},{"key":"e_1_3_3_61_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2958.2006.05235.x"},{"key":"e_1_3_3_62_2","doi-asserted-by":"publisher","DOI":"10.1099\/mic.0.2008\/017475-0"},{"key":"e_1_3_3_63_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkg217"},{"key":"e_1_3_3_64_2","doi-asserted-by":"publisher","DOI":"10.1128\/EC.00215-12"},{"key":"e_1_3_3_65_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature06836"},{"key":"e_1_3_3_66_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-1097(99)00237-2"},{"key":"e_1_3_3_67_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.46.4.1046-1052.2002"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.02217-13","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.02217-13","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T22:53:47Z","timestamp":1645484027000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.02217-13"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":66,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["10.1128\/AAC.02217-13"],"URL":"https:\/\/doi.org\/10.1128\/aac.02217-13","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"2013-10-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2014-05-21","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2014-07-15","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}